A California real estate company has agreed to build a $700 million complex of commercial health care laboratories on the campus of Bellevue Hospital Center, a venture that city officials hope will spur the growth of the biotechnology industry in New York.
The East River Science Park, as the complex would be named, would cover four and a half acres owned by the city’s Health and Hospitals Corporation between 28th and 29th Streets and First Avenue and the Franklin D. Roosevelt Drive. Officials said it was being created to attract the kind of the small start-up companies that are routinely spun off from academic research projects at the city’s universities and hospitals and to appeal to established biotechnology companies now clustered in places like Silicon Valley.
Mr. Bloomberg said the city was already a leading center of bioscience research, and could become “one of the nation’s primary bioscience clusters as well” with the new East Side complex.
The Kansas Biosciences Initiative is funded with $350 million. This is twice as much being put up by a private developer in New York, and as a private project, there are no inherent limits on what research goes on.
That’s the competition Kansas faces in the biotech industry. Why is this developer putting up $700 million to build on spec in NYC, but not in Kansas? I’ve learned my lesson, I’ll let you figure it out for yourself.
If Kansas or Missouri want to be taken seriously as biotech centers, they need to do more than half measures. If they genuinely think evolution and/or stem cells are too immoral, then don’t waste money on biotech.
Money talks. Bullshit walks.